Glenmark Chief: Running A Facility In The US Has Been A Struggle
Firm Primes Global Scale In Respiratory Segment
Glenmark readies scale up in the respiratory segment, with Ryaltris set for a US debut and a filing for a generic rival to Flovent anticipated. Running a facility in that market, though, is not an easy task, says the firm's leadership.
